News & Updates
Filter by Specialty:
Esaxerenone produces favourable night-time BP-lowering effect in Asians
The novel highly selective mineralocorticoid receptor blocker esaxerenone holds promise in the treatment of nocturnal hypertension, yielding substantial reductions in night-time blood pressure (BP), especially in Japanese patients with a riser pattern, as well as in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, according to a post hoc analysis of a phase III study.
Esaxerenone produces favourable night-time BP-lowering effect in Asians
24 Jan 2022
Peak exercise SBP below predicted value tied to future CVD, mortality
A peak systolic blood pressure (SBP) at clinical exercise testing that is slightly lower than the predicted value appears predictive of future cardiovascular disease (CVD) and mortality, suggests a study. Higher peak SBP, however, is not associated with such risks.
Peak exercise SBP below predicted value tied to future CVD, mortality
24 Jan 2022
Upper extremity DVT common in COVID-19 despite proper prophylaxis
About 10 percent of patients with the coronavirus disease 2019 (COVID-19) will suffer from upper extremity deep vein thrombosis despite adequate prophylaxis, a recent study has found.
Upper extremity DVT common in COVID-19 despite proper prophylaxis
21 Jan 2022
Tranexamic acid ups blood control after CABG, but aggravates perioperative myocardial infarction
While tranexamic acid improves blood control after coronary artery bypass graft (CABG) surgery, it increases the risk of perioperative myocardial infarction, a recent study has found.
Tranexamic acid ups blood control after CABG, but aggravates perioperative myocardial infarction
20 Jan 2022
High-salt diet hastens vascular ageing in kids
Increased levels of dietary sodium (Na) intake and load (Na-L) appear to cause arterial stiffness, a preclinical measure of cardiovascular disease (CVD), in children and young adults, according to a study.